- Megan Paquin

Choose the health content that’s right for you, and get it delivered right in your inbox.
The AdventHealth Neuroscience Institute is celebrating a new designation as one of only 20 ELITE GammaTile Centers in the U.S. This recognition comes as the institute’s neurosurgeons and oncologists have successfully completed 10 GammaTile procedures since becoming the first in Central Florida to treat aggressive brain tumors with this advanced technology.
GammaTile Therapy is a novel Surgically Targeted Radiation Therapy (STaRT) for operable brain tumors. Implanted in the last five minutes of brain tumor removal surgery, each bioresorbable, 3D-collagen GammaTile is embedded with radiation sources. GammaTile Therapy delivers a sustained, controlled, therapeutic radiation dose, targeting tumor cells while sparing healthy tissue.

“Our commitment to complete, whole-person neurological care begins with our world-class specialists who consistently seek out leading-edge therapies for our patients,” said Craig Brubaker, vice president of AdventHealth’s Neuroscience Institute. “This milestone exemplifies their dedication, and we are pleased to be able to bring this advanced level of brain care to residents of this community.”
Dr. Melvin Field added, “This innovation is giving our patients a head-start in the fight against brain tumors. With GammaTile, we can immediately and precisely target cancer-involved tissues with a high dose of radiation, potentially extending our patients lives and helping maintain a higher quality of life throughout their treatment.”
In the past 50 years, only seven drugs or devices have been FDA-approved or -cleared to treat brain tumors. The latest advancement in brain tumor treatment, GammaTile Therapy was FDA-cleared in 2018 for recurrent brain tumors, including recurrent high-grade gliomas, glioblastomas, meningiomas and brain metastases. In 2020, the FDA expanded that indication to include newly diagnosed malignant brain tumors. For more information, visit the AdventHealth Neuroscience Institute’s brain tumor program here.
Recent News
AdventHealth Minneola CEO Kay Barnett, featured on The Crossman Conversation podcast.
AdventHealth is thrilled to have Laura M. Sullivan, MSN, APRN, NNP-BC, as part of our care team at The Baby Place at AdventHealth Hendersonville.
AdventHealth’s annual sports physicals event for Flagler Schools will be May 21 and 22 from 5 to 9 p.m. at Flagler Palm Coast High School, 5500 East Highway 100, Palm Coast.
An innovative effort is underway to increase the number of organ donors in minority communities.
April is recognized as IBS Awareness Month, dedicated to educating the public about irritable bowel syndrome (IBS), its symptoms, and the importance of seeking appropriate treatment.
Expected to open by 2026, the AdventHealth Training Center at Jackie Robinson Ballpark will enhance player wellness and support downtown revitalization.
– AdventHealth Manchester is proud to announce the success of our recent Coffee & Conversation event held on National Health Care Decision Day. The event took place at the AdventHealth Primary Care...
AdventHealth and Orange County collaborate to enhance mortality and neurological outcomes at AdventHealth Orlando.
Nicol McGough understands all too well how physical inactivity brought on by illness or injury can severely damage a person’s well-being.
AdventHealth Primary Care Clinic is thrilled to announce the addition of Jessica Napier, PA-C, to our Women's Care Team. Jessica will be joining Dr. Shawn Gorden in providing comprehensive women's...
AdventHealth Heart of Florida and AdventHealth Lake Wales earn prestigious national recognition for promoting organ, eye and tissue donation
AdventHealth Wesley Chapel is proud to announce its groundbreaking achievement as the first hospital in Pasco County to perform a new, minimally invasive renal denervation (RDN) procedure.